Companies /Healthcare

BioNTech SE

NASDAQ: BNTX Biotechnology

$90.62

▲ $1.96 (+2.21%) today

Markets open · 2:12pm ET

BNTX Coverage Page 5

10:04am ET

Health and Healthcare

Pfizer and BioNTech Set to Receive a Sweet Payoff for COVID-19 Vaccines

Pfizer and BioNTech S.E. aim to begin delivering 300 million doses of their vaccine for COVID-19 in 2021, but in the meantime, these companies will get a nice payoff.

BNTX PFE

Chris Lange

11:23am ET

Health and Healthcare

BioNTech Raises Over $400 Million to Boost COVID-19 Efforts

BioNTech is one of the leading companies in the race to a COVID-19 vaccine. With its shares up more than 160% year to date, it’s time to capitalize.

BNTX PFE

Chris Lange

9:52am ET

Health and Healthcare

Pfizer and BioNTech Make Another Big Step for COVID-19 Vaccine

BioNTech and Pfizer are leading the pack of COVID-19 vaccine stocks as this collaboration came out with more positive news regarding their ongoing German Phase 1/2 study.

BNTX PFE

Chris Lange